Deborah Panebianco

MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.

Kathelijne Peerlinck, Inge De Lepeleire, Michael R. Goldberg et al. · Circulation · 1993 · 164 citations · Full text

Medicine, Hematology, Pharmacology +17

Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies

S. Aubrey Stoch, Stefan Zajic, Julie A. Stone et al. · Clinical Pharmacology & Therapeutics · 2009 · 156 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men

Jeffrey S. Barrett, Gail Murphy, Kathelijne Peerlinck et al. · Clinical Pharmacology & Therapeutics · 1994 · 131 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers

Anup Majumdar, Laura Howard, Michael R. Goldberg et al. · The Journal of Clinical Pharmacology · 2006 · 99 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil

Jacqueline B. McCrea, Sreeraj Macha, Adedayo Adedoyin et al. · The Journal of Clinical Pharmacology · 2019 · 85 citations

Pharmacy, Pharmacokinetics, Pharmacology +17